CONDENSED CONSOLIDATED STATEMENTS OF EQUITY (UNAUDITED) - USD ($) shares in Millions, $ in Millions	Total	Shareholders' Equity [Member]	Common Stock [Member]	Add'l Paid-in Capital [Member]	Treasury Stock [Member]	Retained Earnings [Member]	Accum. Other Comp. Loss [Member]		Noncontrolling Interests [Member]
Beginning balance (in shares) at Dec. 31, 2020			9,407		3,840
Beginning balance at Dec. 31, 2020	$ 63,473	$ 63,238	$ 470	$ 88,674	$ (110,988)	$ 90,392	$ (5,310)		$ 235
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	4,886	4,877				4,877			9
Other comprehensive income/(loss), net of tax	647	646					646		1
Cash dividends declared, per share
Common stock	(84)	(84)				(84)
Share-based payment transactions (in shares)			38		11
Share-based payment transactions	(30)	(30)	$ 2	329	$ (361)
Purchases of common stock	0
Other	(27)	(27)				(27)
Ending balance (in shares) at Apr. 04, 2021			9,445		3,851
Ending balance at Apr. 04, 2021	68,865	68,620	$ 472	89,002	$ (111,349)	95,158	(4,664)		245
Beginning balance (in shares) at Dec. 31, 2021			9,471		3,851
Beginning balance at Dec. 31, 2021	77,462	77,201	$ 473	90,591	$ (111,361)	103,394	(5,897)		262
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	7,870	7,864				7,864			6
Other comprehensive income/(loss), net of tax	(260)	(260)					(260)	[1]
Cash dividends declared, per share
Common stock	0
Share-based payment transactions (in shares)			23		12
Share-based payment transactions	(383)	(383)	$ 2	249	$ (570)	(65)
Purchases of common stock (in shares)					(39)
Purchases of common stock	(2,000)	(2,000)			$ (2,000)
Other	(4)	3		3					(7)
Ending balance (in shares) at Apr. 03, 2022			9,494		3,903
Ending balance at Apr. 03, 2022	$ 82,685	$ 82,424	$ 476	$ 90,844	$ (113,931)	$ 111,193	$ (6,157)		$ 261

[1] Amounts do not include foreign currency translation adjustments attributable to noncontrolling interests. Foreign currency translation adjustments include net losses related to our equity method investment in the Consumer Healthcare JV (see Note 2C) and the impact of our net investment hedging program.